Email this article NEW MARKERS FOR CARDIOVASCULAR RISK: FROM STUDIES TO CLINICAL GUIDELINES
- Authors: Anichkov D.A.1, Shostak N.A.1
-
Affiliations:
- Acad. A.I. Nesterov Department of Faculty Therapy, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow
- Issue: Vol 8, No 1 (2014)
- Pages: 4-8
- Section: EDITORIAL
- Published: 23.11.2014
- URL: https://klinitsist.abvpress.ru/Klin/article/view/140
- DOI: https://doi.org/10.17650/1818-8338-2014-1-4-8
- ID: 140
Cite item
Full Text
Abstract
New markers for cardiovascular disease (CVD) risk are the subject of an intensive discussion in the scientific literature. The biomarkers (new
lipid parameters, inflammatory markers) and signs of subclinical atherosclerosis are candidates to be included in models to assess the cumulative risk of CVD. The paper considers the basic studies dealing with new markers of CVD risk and their place in current clinical recommendations.
About the authors
D. A. Anichkov
Acad. A.I. Nesterov Department of Faculty Therapy, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow
Author for correspondence.
Email: d.anichkov@gmail.com
Russian Federation
N. A. Shostak
Acad. A.I. Nesterov Department of Faculty Therapy, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, MoscowRussian Federation
References
Supplementary files
